Over the few decades, potential applications for stem cells have expanded to include their use as:
- Research tools
- Cell therapies
- Source materials for 3D printing and 3D weaving
- Drug target validation
- Toxicology screening
- And More
Your Global Leader in Stem Cell Market Research
Guest Author: This article was authored by Alex Diaz-Granados, Chief Editor at Cerebral Palsy Guidance.
Cerebral palsy is a neurological condition that affects thousands of babies born every year. Damage or malformation of the brain during development, most often in the womb, leads to motor and muscle symptoms. Children with cerebral palsy face a lifelong disability with consequences ranging from being wheelchair bound to painful, tight muscles and joints and even hearing loss, vision loss, cognitive deficits, and many more symptoms and complications that vary by individual. [Read more…]
HAIFA, ISRAEL, JULY 26, 2017— Pluristem Therapeutics Inc. (NASDAQ: PSTI) (TASE: PSTI), a leading developer of placenta-based cell therapy products, today presented new data at the RITN (Radiation Injury Treatment Network) conference from a recent study evaluating PLX-R18 as a treatment for Acute Radiation Syndrome (ARS). [Read more…]
FREEPORT, GRAND BAHAMA, JULY 26, 2017 — Vincent R. Burton, MBBS, FRCA, has been appointed President of Okyanos Center for Regenerative Medicine, which is licensed by the Bahamas’ National Stem Cell Ethics Committee (NSCEC).
Dr. Burton received his Bachelor of Medicine, Bachelor of Surgery degree (MBBS) from the University of the West Indies. He went on to complete residency training in the United Kingdom at Queen’s Hospital of Staffordshire, Norfolk and Norwich University Hospital as well as Cambridge University’s Addenbrooke’s Hospital. He is a Fellow of the Royal College of Anaesthetists (FRCA) and has served as Chief Anesthesiologist at Okyanos since the center opened in 2014. [Read more…]
Traditionally, the contract development and manufacturing organization (CDMO) market was for pharmaceutical services, including drug compound development and manufacturing. Over time, many pharmaceutical companies expanded into offering services for biopharmaceuticals and biologics as well, and a companies went as far as to specialize in cell therapy CDMO services. [Read more…]